In our October issue:
FEATURES
Cover Story
The Gate Keeper: Dr. David Haslam, Chair of NICE (UK)
Leela Barham
Pharm Exec sits down with Dr. David Haslam, Chair of the UK's National Institute for Health and Care Excellence (NICE), to discuss the agency's new challenge in meeting the diverse expectations around what the quantitative calculations of value mean to patient access in today's world of real-time medicine. |
M&A Outlook
Dealmaking: Staying Ahead of the Curve
Michael Swanick
Amid the continued surge in asset swiping and switching, what are the crucial considerations pharma executives should weigh before sitting down at the deals table. |
From the Editor
How the “Millennials” Demographic is Shaping US Healthcare
William Looney
The US is skewing young again, and the "millennials" have the clout to color everything from the nation's cultural landscape to the conduct of business practices like marketing and customer engagement, writes Pharm Exec Editor-in-Chief William Looney. |
European Pharma Perspective
IDEAlogue for Innovation
Fabio Pammolli
Leading European economist Professor Fabio Pammolli outlines the progress of the biopharmaceuticals competitiveness agenda in Brussels and identifies current dilemmas facing health and pharma regulators in Europe today. |
 |
ALSO IN THIS ISSUE
Ebola Crisis Challenges Pharma R&D
Jill Wechsler
Companies gain support — and pressure — to deliver treatments for the spreading outbreak.
Gain Competitive Advantage — Think Like a Navy SEAL
Stan Bernard
Pharma professionals, teams, and organizations can succeed at an elite level by tackling the tough mental challenges of Navy SEAL training. |
